Detalhe da pesquisa
1.
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Eur J Clin Invest
; 51(4): e13421, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33022756
2.
Can Rituximab Improve the Outcome of Patients with Nodular Lymphocyte-Predominant Hodgkin's Lymphoma?
Acta Haematol
; 134(3): 187-92, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26021284
3.
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders.
Orphanet J Rare Dis
; 14(1): 9, 2019 01 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30626415
4.
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a single-center, retrospective study.
Leuk Lymphoma
; 56(7): 2013-8, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25330440
5.
Is severe cardiac dysfunction a contraindication for complex combined oncotherapy of Hodgkin's lymphoma? Not any more.
ASAIO J
; 59(3): 320-1, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23644622
6.
Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.
Leuk Res
; 34(9): e232-4, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20226523